# Inflammation and Insulin Resistance in Rheumatoid Arthritis

> **NCT00763139** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 34 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00763139
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-09
- **Final completion:** 2013-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763139, "Inflammation and Insulin Resistance in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00763139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*